TRK-001

N/A

Report date: 2025/11/05 20:01:16

Base Information

Drug NameTRK-001
Drug Alias NameTRK-001
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionRegulatory T-lymphocytes modulators
TargetsNot applicable
Therapy Area/IndicationsRejection of liver transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTract Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesTract Therapeutics
Inactive CompaniesN/A
Active IndicationsRejection of liver transplantation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A